BARGAGNA, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 177
EU - Europa 111
AS - Asia 95
SA - Sud America 19
AF - Africa 12
Totale 414
Nazione #
US - Stati Uniti d'America 173
IT - Italia 54
SG - Singapore 45
CN - Cina 22
HK - Hong Kong 16
BR - Brasile 15
DE - Germania 12
CI - Costa d'Avorio 8
FR - Francia 8
NL - Olanda 8
PL - Polonia 6
SE - Svezia 6
GB - Regno Unito 5
FI - Finlandia 4
SN - Senegal 4
AR - Argentina 3
AT - Austria 3
BG - Bulgaria 3
CA - Canada 3
VN - Vietnam 3
JP - Giappone 2
KZ - Kazakistan 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CR - Costa Rica 1
IN - India 1
IQ - Iraq 1
NO - Norvegia 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 414
Città #
Dallas 45
Ashburn 25
Santa Clara 21
Singapore 19
Hong Kong 16
Shanghai 11
Abidjan 8
Milan 8
New York 8
Boardman 7
Los Angeles 7
Frankfurt am Main 6
Pisa 6
Chandler 5
Florence 5
Munich 5
Rome 5
Venice 5
Warsaw 5
Dakar 4
Fairfield 4
London 4
Marseille 4
Turku 4
Houston 3
Sofia 3
Beijing 2
Cascina 2
Fairburn 2
Fisciano 2
Genoa 2
Redondo Beach 2
Seattle 2
Vienna 2
Wilmington 2
Almaty 1
Amsterdam 1
Astana 1
Atlanta 1
Baghdad 1
Barretos 1
Buffalo 1
Calgary 1
Cambridge 1
Chengdu 1
Chennai 1
Cleveland 1
Colatina 1
Conquista 1
Curaçá Municipality 1
Denver 1
Duisburg 1
Formiga 1
Franklin 1
Fuzhou 1
Guarulhos 1
Ho Chi Minh City 1
Hưng Yên 1
Itabaiana 1
Itabuna 1
Kent 1
La Fortuna 1
Lauterbourg 1
Lawrence 1
Leandro N. Alem 1
Lucca 1
Manassas 1
Maracaibo 1
Mariano Moreno 1
Montreal 1
Muriaé 1
Newark 1
Ogden 1
Osaka 1
Paris 1
Petrópolis 1
Poplar 1
Porto Alegre 1
Princeton 1
Quanzhou 1
Queens 1
Salvador 1
San Giuliano Terme 1
San Jose 1
San Miguel 1
Santos 1
Secaucus 1
Stockholm 1
São Paulo 1
Tashkent 1
Toffia 1
Tokyo 1
Viamão 1
Wuhan 1
Yantai 1
Totale 321
Nome #
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 137
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 111
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 97
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC 78
Totale 423
Categoria #
all - tutte 1.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 3 0 4 1 1 4
2021/202213 0 0 0 0 2 5 1 3 0 1 0 1
2022/202345 2 1 2 1 1 6 0 1 26 0 5 0
2023/202450 3 7 9 1 1 8 5 2 0 3 5 6
2024/2025153 3 5 0 8 17 19 16 10 20 21 18 16
2025/2026149 15 33 29 24 30 17 1 0 0 0 0 0
Totale 423